Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Lutetium Lu 177 dotatate by Advanced Accelerator Applications for Pheochromocytoma: Likelihood of Approval
Lutetium Lu 177 dotatate is under clinical development by Advanced Accelerator Applications and currently in Phase II for Pheochromocytoma. According...
Lutetium Lu 177 dotatate by Advanced Accelerator Applications for Small-Cell Lung Cancer: Likelihood of Approval
Lutetium Lu 177 dotatate is under clinical development by Advanced Accelerator Applications and currently in Phase II for Small-Cell Lung...
Lutetium Lu 177 dotatate by Curium Midco for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET): Likelihood of Approval
Lutetium Lu 177 dotatate is under clinical development by Curium Midco and currently in Pre-Registration for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)....